Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2013
10/31/2013WO2013093637A3 Plant treatment methods and means therefor
10/31/2013WO2013040212A3 Unique transcriptional signatures in the blood of clinical responders
10/31/2013WO2004061073A9 Novel human proteins, polynucleotides encoding them and methods of using the same
10/31/2013WO2003044159A9 Zinc finger proteins, polynucleotides encoding same and antibodies thereto
10/31/2013WO2003027257A9 Methods of controlling gene expression and gene silencing
10/31/2013WO2003023014A9 Human ion channels
10/31/2013WO2003020910A9 POLYNUCLEOTIDE ENCODING A NOVEL HUMAN POTASSIUM CHANNEL BETA-SUBUNIT, K+betaM8
10/31/2013WO2002101078A9 Cellulases, nucleic acids encoding them and methods for making and using them
10/31/2013WO2002098346A3 Method and pharmaceutical composition for the treatment of multiple sclerosis
10/31/2013WO2002087500A3 Viral enzyme activated prototoxophores and use of same to treat viral infections
10/31/2013WO2002078598A3 Peptides and antibodies to muc 1 proteins
10/31/2013WO2002077260A9 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
10/31/2013WO2002077001A9 Novel receptors
10/31/2013WO2002059349A9 Odorant receptors and uses thereof
10/31/2013US20130291235 Brassica plant comprising a mutant alcatraz allele
10/31/2013US20130291234 Salt tolerance sydbsp gene derived from synechocystis, and uses thereof
10/31/2013US20130291233 Methods and Compositions for Modified Ethanol Inducible Promoter Systems
10/31/2013US20130291232 Dna involved in gene expression regulation in photosynthetic tissue
10/31/2013US20130291231 Mature leaf-specific promoter
10/31/2013US20130291229 Modification of sucrose distribution in plants
10/31/2013US20130291226 P5sm suicide exon for regulating gene expression
10/31/2013US20130291224 Method for speeding up plant growth and improving yield by introducing phosphatases in transgenic plant
10/31/2013US20130291223 Polynucleotides, polypeptides and methods for increasing oil content, growth rate and biomass of plants
10/31/2013US20130291222 Environmental stress-inducible promoter and its application in crops
10/31/2013US20130291221 Method for production of plant imparted with stress tolerance and use thereof
10/31/2013US20130291220 Genes Involved in Tolerance to Environmental Stress
10/31/2013US20130291188 Down-regulating gene expression in insect pests
10/31/2013US20130291175 Plants and seeds of hybrid corn variety ch685922
10/31/2013US20130289265 Methods and compositions for extraction and storage of nucleic acids
10/31/2013US20130289262 ACP Promoter
10/31/2013US20130289259 Aptamer labelled with f-19 nucleus for targeted molecular imaging by mri
10/31/2013US20130289258 Methods of inducing insulin production
10/31/2013US20130289243 Collagen producing plants and methods of generating and using same
10/31/2013US20130289100 Subunit-selective nucleic acid inhibitors of glutamate receptors
10/31/2013US20130289099 Abcg1 gene as a marker and a target gene for treating obesity
10/31/2013US20130289098 Compositions and methods for treatment of ovarian cancer
10/31/2013US20130289097 Compositions for conferring tolerance to viral disease in social insects, and the use thereof
10/31/2013US20130289096 Oligomers
10/31/2013US20130289094 Compositions and Methods for Inhibition of PCSK9 Genes
10/31/2013US20130289093 Microrna compounds and methods for modulating mir-21 activity
10/31/2013US20130289092 Compounds and methods for modulating interaction between proteins and target nucleic acids
10/31/2013US20130289091 Antisense antibacterial method and compound
10/31/2013US20130288929 Method for Making an Enriched Library
10/31/2013US20130288905 Methods for detecting modification resistant nucleic acids
10/31/2013US20130288898 Methods and compositions for providing tolerance to multiple herbicides
10/31/2013US20130288895 Methods and compositions for weed control
10/31/2013US20130288377 Compositions and methods for modulating the sensitivity of cell to ahas inhibitors
10/31/2013US20130288369 dsRNA MOLECULES COMPRISING OLIGONUCLEOTIDE ANALOGS HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS
10/31/2013US20130288342 Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of dna
10/31/2013US20130288335 Method to improve the stability and broaden the ph range of family g/11 xylanases
10/31/2013US20130288333 Protein complex using an immunoglobulin fragment and method for the preparation thereof
10/31/2013US20130288325 Biofuel and chemical production by recombinant microorganisms via fermentation of proteinaceous biomass
10/31/2013US20130288297 Artificial biological materials produced by self-assembly of photosynthetic unicells
10/31/2013US20130288251 Lactococcus crispr-cas sequences
10/31/2013US20130288234 Device for preparing a sample
10/31/2013US20130288231 Universal multi-variant detection system
10/31/2013US20130287814 DNA Expression Construct
10/31/2013US20130287803 Novel uses of vegfxxxb
10/31/2013US20130287793 QSOX1 as an Anti-Neoplastic Drug Target
10/31/2013US20130287785 Gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof
10/31/2013US20130287782 Enterococcus antigens
10/31/2013US20130287762 Neutralizing antibodies against gdf-8 and uses therefor
10/31/2013US20130287738 Disease-associated protein
10/31/2013US20130287736 Gene therapy for neurodegenerative disorders
10/31/2013US20130287695 Chondrocyte-like cell, and method for producing same
10/31/2013US20130287693 NOGO Receptor Binding Protein
10/30/2013EP2657703A1 Test kit for plasma or serum antibody titer against periodontal disease-causing bacteria
10/30/2013EP2657702A1 Analytical device and analytical method
10/30/2013EP2657342A1 DNA dendrimers protected against nuclease degradation are useful as vectors for the delivery of siRNA
10/30/2013EP2657341A2 Plants having enhanced yield-related traits and a method for making the same
10/30/2013EP2657340A1 Inhibitors of thioredoxin-interacting protein (TXNIP) for therapy
10/30/2013EP2657339A2 Gene delivery system having enhanced tumor-specific expression, and recombinant gene expression regulating sequence
10/30/2013EP2657338A1 HLA-binding peptide, and DNA fragment and recombinant vector coding for said HLA-binding peptide
10/30/2013EP2657337A1 Fusion protein
10/30/2013EP2657336A1 Bioassay method for detecting physiologically active substance
10/30/2013EP2657333A1 Porcine circovirus type 2, immune composition containing the same, assay kit, and use thereof
10/30/2013EP2657332A1 Methods for producing an amino acid of the L-glutamic acid family
10/30/2013EP2657330A1 Detection tool, and detection system
10/30/2013EP2657267A1 Bioactive surface capable of genetically modifying biological cells or tissues and use thereof
10/30/2013EP2657253A2 Anti-CD79b antibodies and immunoconjugates and methods of use
10/30/2013EP2657252A2 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof and method for preparing same
10/30/2013EP2657251A1 Live, oral vaccine for protection against Shigella dysenteriae serotype 1
10/30/2013EP2657250A2 Variant polypeptide having homoserine acetyltransferase activity and microorganism expressing same
10/30/2013EP2657249A2 Novel o-acetylhomoserine sulfhydrylase or variant thereof, and method for transforming methionine using same
10/30/2013EP2657248A1 AAV virions with decreased immunoreactivity and uses therefor
10/30/2013EP2657247A1 AAV virions with decreased immunoreactivity and uses therefor
10/30/2013EP2656850A2 Oligonucleotides for the treatment or alleviation of edema
10/30/2013EP2655669A1 Expression process
10/30/2013EP2655663A2 Biomarkers and uses thereof in prognosis and treatment strategies for right-side colon cancer disease and left-side colon cancer disease
10/30/2013EP2655650A2 Enzymatic synthesis of active pharmaceutical ingredient and intermediates thereof
10/30/2013EP2655646A2 Targeted perhydrolases
10/30/2013EP2655636A1 Modified human cmv promoters that are resistant to gene silencing
10/30/2013EP2655635A1 Viral promoter, truncations thereof, and methods of use
10/30/2013EP2655634A1 Method for expressing deoxyribonuclease in plants
10/30/2013EP2655633A1 Disruption of ahp6 gene leads to plants with improved seed yield
10/30/2013EP2655632A1 Viral promoter, truncations thereof, and methods of use
10/30/2013EP2655631A1 Method for producing mullerian inhibitor substance in plants
10/30/2013EP2655630A1 Method for producing apolipoprotein in plants
10/30/2013EP2655629A1 Brassica plant comprising a mutant alcatraz allele
10/30/2013EP2655628A1 Alpha-mannosidases from plants and methods for using the same
1 ... 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 ... 4023